In the PC-3 cancer cell line, treatment with KA39 at IC50 for 72 h resulted in a significant increase in PD-L1 expression (27.28%; p < 0.05) (Figure 2D; Figures S16–S20; Tables S16–S20; Table 5). The gene discussed is CD274; the disease is cancer.